These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


228 related items for PubMed ID: 7018670

  • 1. Activity of 4'-(9-acridinylamino)methanesulfon-m-anisidide against Chinese hamster cells in multicellular spheroids.
    Wilson WR, Whitmore GF, Hill RP.
    Cancer Res; 1981 Jul; 41(7):2817-22. PubMed ID: 7018670
    [Abstract] [Full Text] [Related]

  • 2. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
    Wilson WR, Giesbrecht JL, Hill RP, Whitmore GF.
    Cancer Res; 1981 Jul; 41(7):2809-16. PubMed ID: 6894713
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells.
    Wilson WR, Harris NM, Ferguson LR.
    Cancer Res; 1984 Oct; 44(10):4420-31. PubMed ID: 6547875
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures.
    Robbie MA, Baguley BC, Denny WA, Gavin JB, Wilson WR.
    Cancer Res; 1988 Jan 15; 48(2):310-9. PubMed ID: 2825971
    [Abstract] [Full Text] [Related]

  • 5. Cell-cycle-stage specificity of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and interaction with ionizing radiation in mammalian cell cultures.
    Wilson WR, Whitmore GF.
    Radiat Res; 1981 Jul 15; 87(1):121-36. PubMed ID: 7019954
    [No Abstract] [Full Text] [Related]

  • 6. Effects of amsacrine and other DNA-intercalating drugs on nuclear and nucleolar structure in cultured V79 Chinese hamster cells and PtK2 rat kangaroo cells.
    Jensen CG, Wilson WR, Bleumink AR.
    Cancer Res; 1985 Feb 15; 45(2):717-25. PubMed ID: 3838148
    [Abstract] [Full Text] [Related]

  • 7. Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
    Odaimi M, Andersson BS, McCredie KB, Beran M.
    Cancer Res; 1986 Jul 15; 46(7):3330-3. PubMed ID: 3754787
    [Abstract] [Full Text] [Related]

  • 8. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
    Covey JM, Kohn KW, Kerrigan D, Tilchen EJ, Pommier Y.
    Cancer Res; 1988 Feb 15; 48(4):860-5. PubMed ID: 2827887
    [Abstract] [Full Text] [Related]

  • 9. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
    Woodcock TM, Schneider RJ, Young CW.
    Cancer Treat Rep; 1980 Jan 15; 64(1):53-5. PubMed ID: 6892893
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
    Erlichman C, Vidgen D.
    Cancer Res; 1984 Nov 15; 44(11):5369-75. PubMed ID: 6488191
    [Abstract] [Full Text] [Related]

  • 11. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.
    Ahmann FR, Meyskens FL, Moon TE, Durie BG, Salmon SE.
    Cancer Res; 1982 Nov 15; 42(11):4495-8. PubMed ID: 6897012
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG.
    Cancer Res; 1993 Mar 01; 53(5):1064-71. PubMed ID: 8382551
    [Abstract] [Full Text] [Related]

  • 16. Comparison of DNA-protein cross-links induced by 4'-(9-acridinylamino)-methanesulfon-m-anisidide and by gamma-radiation.
    Chiu SM, Xue LY, Friedman LR, Oleinick NL.
    Cancer Res; 1989 Feb 15; 49(4):910-4. PubMed ID: 2912561
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
    Frankel A, Buckman R, Kerbel RS.
    Cancer Res; 1997 Jun 15; 57(12):2388-93. PubMed ID: 9192815
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of 4'-(9-acridinylamino)methanesulfon-m-anisidide by rat liver microsomes.
    Shoemaker DD, Cysyk RL, Gormley PE, DeSouza JJ, Malspeis L.
    Cancer Res; 1984 May 15; 44(5):1939-45. PubMed ID: 6546898
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS, Hall SW, Powell KC, Burgess MA, Benjamin RS, Gutterman JU, Bodey GP.
    Cancer Clin Trials; 1980 May 15; 3(2):111-4. PubMed ID: 6893573
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.